Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
Articles on amlodipine & combinations from NPS RADARArticles on amlodipine & combinations from NPS RADAR
(am-LOD-i-peen)
(am-LOD-i-peen with a-TOR-va-stat-in)
| Title | Content Type | Date | Description |
|---|---|---|---|
| Telmisartan with amlodipine fixed-dose combination tablets (Twynsta) PBS listed | Professional publication - NPS RADAR - Brief item | 2011-06-01 00:00:00 | Telmisartan with amlodipine fixed-dose combination tablets (Twynsta) PBS listed |
| New dual and triple antihypertensive combinations PBS listed — be aware of potential confusion | Professional publication - NPS RADAR - Brief item | 2010-11-10 00:00:00 | From 1 November 2010, olmesartan with amlodipine (Sevikar), and valsartan with amlodipine and hydrochlorothiazide (Exforge HCT), can be prescribed for people whose hypertension is inadequately controlled with one of the component drugs at equivalent doses (for dual therapy) or any two of the component drugs (for triple therapy). |
| Valsartan (Diovan) and combinations with hydrochlorothiazide (Co-Diovan) or amlodipine (Exforge) | Professional publication - NPS RADAR - Review | 2009-03-10 00:00:00 | Valsartan reduces blood pressure to a similar extent as other angiotensin II-receptor antagonists. If blood pressure is not controlled by valsartan 160 mg, add a second drug rather than increasing the dose to 320 mg. Establish the effective dose using the individual drugs before prescribing the appropriate combination. |
| Amlodipine with atorvastatin (Caduet) for dyslipidaemia with concomitant hypertension or angina | Professional publication - NPS RADAR - Review | 2006-12-01 00:00:00 | Reviews use of amlodipine/atorvastatin combination for concurrent dyslipidaemia, hypertension, and angina in comparison with use as single agent therapy. |
View all RADAR articles by date, by therapeutic topic, or by active ingredient, or find out more about NPS RADAR.
NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-30 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
